Most anticancer drugs that enter clinical testing in children and adolescents fail to reach late-phase trials or earn pediatric regulatory approval, according to the authors of new research. Over a 15 ...
Adverse drug reactions (ADRs) represent a significant cause of morbidity and mortality in children, who face distinct pharmacological vulnerabilities due to unique physiological development. Current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results